RARA and metabolic syndrome: Recently, the interaction between dyslipidemia-related genes and hematologic malignancy genes has been reported; for instance, the PML/RARα fusion protein and peroxisome proliferator-activated receptor-α have a synergistic effect on acute promyelocytic leukemia (30).